Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does ETANERCEPT Cause Ill-defined disorder? 4,202 Reports in FDA Database

Grow Your Own Natural Pharmacy at Home

Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.

Get the Kit

According to the FDA Adverse Event Reporting System (FAERS), 4,202 reports of Ill-defined disorder have been filed in association with ETANERCEPT (ENBREL). This represents 1.2% of all adverse event reports for ETANERCEPT.

4,202
Reports of Ill-defined disorder with ETANERCEPT
1.2%
of all ETANERCEPT reports
947
Deaths
1,545
Hospitalizations

How Dangerous Is Ill-defined disorder From ETANERCEPT?

Of the 4,202 reports, 947 (22.5%) resulted in death, 1,545 (36.8%) required hospitalization, and 1,065 (25.3%) were considered life-threatening.

Is Ill-defined disorder Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for ETANERCEPT. However, 4,202 reports have been filed with the FAERS database.

What Other Side Effects Does ETANERCEPT Cause?

Drug ineffective (60,367) Rheumatoid arthritis (33,166) Pain (31,961) Arthralgia (27,429) Injection site pain (24,717) Off label use (20,178) Fatigue (19,907) Joint swelling (18,462) Injection site erythema (17,736) Condition aggravated (15,897)

What Other Drugs Cause Ill-defined disorder?

ACETAMINOPHEN\OXYCODONE (9,780) ACETAMINOPHEN\HYDROCODONE (6,159) TOCILIZUMAB (4,411) RITUXIMAB (4,220) METHOTREXATE (4,063) ABATACEPT (3,630) LUTETIUM LU-177 VIPIVOTIDE TETRAXETAN (3,600) LEFLUNOMIDE (3,570) CERTOLIZUMAB PEGOL (3,273) GOLIMUMAB (3,122)

Which ETANERCEPT Alternatives Have Lower Ill-defined disorder Risk?

ETANERCEPT vs ETANERCEPT-SZZS ETANERCEPT vs ETELCALCETIDE ETANERCEPT vs ETEPLIRSEN ETANERCEPT vs ETESEVIMAB ETANERCEPT vs ETHACRYNIC ACID

Related Pages

ETANERCEPT Full Profile All Ill-defined disorder Reports All Drugs Causing Ill-defined disorder ETANERCEPT Demographics